Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04621929 · ClinicalTrials.gov registry record · Phase 2
Phentermine/Topiramate for Uric Acid Stones
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT04621929 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 19 participants.
The verdict
NCT04621929, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The investigator proposes an 18 month, feasibility pilot study, randomizing obese and diabetic individuals with pure uric acid nephrolithiasis (UAN) or mixed calcium oxalate (CO) UAN to either phentermine/topiramate or a pragmatic control group who will remain on their standard medication regimen (citrate salts, allopurinol, diet, etc.).
Interventions
- DRUG Phentermine / Topiramate Oral Product
- COMBINATION_PRODUCT Citrate Salts, Allopurinol, Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2024-11-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04621929
The ClinicalTrials.gov registry entry for NCT04621929 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phentermine / Topiramate Oral Product is the first listed.
NCT04621929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04621929 about?
NCT04621929 is a clinical study titled "Phentermine/Topiramate for Uric Acid Stones". The investigator proposes an 18 month, feasibility pilot study, randomizing obese and diabetic individuals with pure uric acid nephrolithiasis (UAN) or mixed calcium oxalate (CO) UAN to either phentermine/topiramate or a pragmatic control group who will remain on their standard medication regimen (c...
What is the current status of trial NCT04621929?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2021-03-31. Estimated completion is 2024-11-14.
What interventions are being tested in trial NCT04621929?
The interventions under investigation include: Phentermine / Topiramate Oral Product (DRUG), Citrate Salts, Allopurinol, Diet (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04621929?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.